For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Anavex Life Sciences Corporation’s stock clocked out at $9.57, up 1.70% from its previous closing price of $9.41. In other words, the price has increased by $1.70 from its previous closing price. On the day, 0.62 million shares were traded. AVXL stock price reached its highest trading level at $9.6 during the session, while it also had its lowest trading level at $9.2878.
Ratios:
To gain a deeper understanding of AVXL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 817009088 and an Enterprise Value of 701237632.
Stock Price History:
The Beta on a monthly basis for AVXL is 0.70, which has changed by 1.2677724 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $3.78. The 50-Day Moving Average of the stock is 12.16%, while the 200-Day Moving Average is calculated to be 15.52%.
Shares Statistics:
It appears that AVXL traded 944.53K shares on average per day over the past three months and 825490 shares per day over the past ten days. A total of 85.33M shares are outstanding, with a floating share count of 82.52M. Insiders hold about 3.35% of the company’s shares, while institutions hold 36.91% stake in the company. Shares short for AVXL as of 1749772800 were 25212383 with a Short Ratio of 26.69, compared to 1747267200 on 24099499. Therefore, it implies a Short% of Shares Outstanding of 25212383 and a Short% of Float of 30.54.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating of Anavex Life Sciences Corporation (AVXL) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.52 and -$0.6 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is $2.35, with 2.0 analysts recommending between $5.19 and -$0.49.
